BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37730975)

  • 1. BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice.
    Liu A; Li X; Zhou L; Yan X; Xia N; Song Z; Cao J; Hao Z; Zhang Z; Liang R; Zhang H
    Environ Sci Pollut Res Int; 2023 Oct; 30(48):106549-106561. PubMed ID: 37730975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
    Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of DNA methylation and
    Liu A; Li X; Hao Z; Cao J; Li H; Sun M; Zhang Z; Liang R; Zhang H
    Toxicol Ind Health; 2022 Mar; 38(3):127-138. PubMed ID: 35193440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
    Tung JN; Wu HH; Chiang CC; Tsai YY; Chou MC; Lee H; Cheng YW
    Mol Vis; 2010 Apr; 16():623-9. PubMed ID: 20700368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
    Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
    Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
    Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione conjugation and DNA adduct formation of dibenzo[a,l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases.
    Sundberg K; Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2002 Feb; 15(2):170-9. PubMed ID: 11849043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
    Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
    Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
    Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
    Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy.
    Beranek M; Fiala Z; Kremlacek J; Andrys C; Hamakova K; Chmelarova M; Palicka V; Borska L
    Toxicol Lett; 2016 Jul; 255():47-51. PubMed ID: 27188524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
    Shiizaki K; Kawanishi M; Yagi T
    Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer].
    Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo(a)pyrene diolepoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons: association with specific CYP1A1, GSTM1, GSTP1 and EHPX genotypes.
    Pastorelli R; Cerri A; Rozio M; Dell'Omo M; Muzi G; Abbritti G; Fanelli R; Airoldi L
    Biomarkers; 2001; 6(5):357-74. PubMed ID: 23889309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
    Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
    Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse.
    Sticha KR; Staretz ME; Wang M; Liang H; Kenney PM; Hecht SS
    Carcinogenesis; 2000 Sep; 21(9):1711-9. PubMed ID: 10964103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
    Pavanello S; Siwinska E; Mielzynska D; Clonfero E
    Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mutagenicity and cytotoxicity of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol and (+/-)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide in genetically engineered human fibroblasts.
    Quan T; Reiners JJ; Culp SJ; Richter P; States JC
    Mol Carcinog; 1995 Feb; 12(2):91-102. PubMed ID: 7662121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.